Clinical Trials Browser

Phase 3 × capivasertib × 90 days × Clear all

NCT06982521 2026-03-03

ReDiscover-2

Phase 3 Recruiting

Breast Neoplasms

NCT07281833 2026-02-27

CAPIcorn

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT04493853 2026-01-20

CAPItello-281

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT06635447 2026-01-13

CAPItrue

Phase 3 Recruiting

Breast Neoplasms, Disease Progression

NCT06764186 2026-01-13

CAPItana

Phase 3 Active not recruiting

Breast Neoplasms

NCT03997123 2025-12-22

CAPItello-290

Phase 3 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms